These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10458236

  • 1. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
    Apostolidis J, Foran JM, Johnson PW, Norton A, Amess J, Matthews J, Bradburn M, Lister TA, Rohatiner AZ.
    J Clin Oncol; 1999 Jan; 17(1):216-21. PubMed ID: 10458236
    [Abstract] [Full Text] [Related]

  • 2. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
    Rohatiner AZ, Johnson PW, Price CG, Arnott SJ, Amess JA, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J.
    J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380
    [Abstract] [Full Text] [Related]

  • 3. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS.
    J Clin Oncol; 2007 Jun 20; 25(18):2554-9. PubMed ID: 17515573
    [Abstract] [Full Text] [Related]

  • 4. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
    Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN.
    Bone Marrow Transplant; 1999 Feb 20; 23(3):227-33. PubMed ID: 10084253
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS.
    Biol Blood Marrow Transplant; 2007 Sep 20; 13(9):1057-65. PubMed ID: 17697968
    [Abstract] [Full Text] [Related]

  • 6. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
    Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE, Salam A, Adams K, Norton AJ, Amess JA, Matthews J, Bradburn M, Lister TA, Rohatiner AZ.
    J Clin Oncol; 2000 Feb 20; 18(3):527-36. PubMed ID: 10653868
    [Abstract] [Full Text] [Related]

  • 7. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
    Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM.
    Blood; 1996 Oct 01; 88(7):2780-6. PubMed ID: 8839876
    [Abstract] [Full Text] [Related]

  • 8. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov 01; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 9. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS, Neuberg D, Gribben JG, Mauch P, Soiffer RJ, Fisher DC, Anderson KC, Andersen N, Schlossman R, Kroon M, Ritz J, Aster J, Nadler LM.
    J Clin Oncol; 1998 Jan 01; 16(1):13-8. PubMed ID: 9440717
    [Abstract] [Full Text] [Related]

  • 10. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.
    Foran JM, Apostolidis J, Papamichael D, Norton AJ, Matthews J, Amess JA, Lister TA, Rohatiner AZ.
    Ann Oncol; 1998 Aug 01; 9(8):865-9. PubMed ID: 9789609
    [Abstract] [Full Text] [Related]

  • 11. Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma.
    Rohatiner AZ, Price CG, Arnott S, Norton A, Evans ML, Cotter F, Dorey E, Davis CL, Clark P, Sterlini J.
    Ann Oncol; 1991 Feb 01; 2 Suppl 2():147-50. PubMed ID: 2049312
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
    Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossman R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG.
    Blood; 1999 Nov 15; 94(10):3325-33. PubMed ID: 10552941
    [Abstract] [Full Text] [Related]

  • 13. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
    Rohatiner AZ, Freedman A, Nadler L, Lim J, Lister TA.
    Ann Oncol; 1994 Nov 15; 5 Suppl 2():143-6. PubMed ID: 8204513
    [Abstract] [Full Text] [Related]

  • 14. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
    Johnson PW, Price CG, Smith T, Cotter FE, Meerabux J, Rohatiner AZ, Young BD, Lister TA.
    J Clin Oncol; 1994 Apr 15; 12(4):798-805. PubMed ID: 8151322
    [Abstract] [Full Text] [Related]

  • 15. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
    Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Robertson MJ.
    J Clin Oncol; 1993 May 15; 11(5):931-6. PubMed ID: 8487057
    [Abstract] [Full Text] [Related]

  • 16. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
    Horning SJ, Negrin RS, Hoppe RT, Rosenberg SA, Chao NJ, Long GD, Brown BW, Blume KG.
    Blood; 2001 Jan 15; 97(2):404-9. PubMed ID: 11154216
    [Abstract] [Full Text] [Related]

  • 17. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS.
    Biol Blood Marrow Transplant; 1999 Jan 15; 5(4):262-8. PubMed ID: 10465106
    [Abstract] [Full Text] [Related]

  • 18. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB, Vowels MR, Shaw PJ, Lockwood L, Mameghan H.
    J Clin Oncol; 1995 Nov 15; 13(11):2789-95. PubMed ID: 7595740
    [Abstract] [Full Text] [Related]

  • 19. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK.
    J Clin Oncol; 1992 Dec 15; 10(12):1949-54. PubMed ID: 1453209
    [Abstract] [Full Text] [Related]

  • 20. Myeloablative therapy for follicular lymphoma.
    Rohatiner AZ, Lister TA.
    Hematol Oncol Clin North Am; 1991 Oct 15; 5(5):1003-12. PubMed ID: 1938753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.